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Velvet antler of deer (VAD) is a commonly-used kidney-Yang supplementing traditional Chinese medication. According to the
heart-kidney-related theory, heart Yang originates in kidney Yang and heart failure due to heart Yang deﬁciency can be treated
by tonifying kidney Yang. In this study, we investigated therapeutic eﬀects of VAD on cardiac functions in rats with heart failure
following myocardial infarction. Forty-eight male Wistar rats were subjected either to left coronary artery ligation (N = 36)
or to sham operation (N = 12). One week after the surgery, rats with heart failure received daily treatment of double-distilled
water, captopril or VAD by gavage for consecutively four weeks, while sham-operated animals were given double-distilled water.
Ultrasonic echocardiography was adopted to examine cardiac structural and functional parameters and serum brain natriuretic
peptide (BNP) concentration was measured using radioimmunoassay. We found that VAD partially reversed changes in cardiac
functional parameters and serum BNP levels in rats with heart failure. These results provide further evidence for the heart-kidney-
related theory and suggest that VAD might be a potentially alternative and complementary medicine for the treatment of heart
failure.
1.Introduction
Velvet antler of deer (VAD) is a precious traditional Chinese
medication,warminnatureandsweetandsaltyinﬂavor,and
is commonly used to treat various diseases by supplementing
kidney Yang. According to TCM theories, kidney Yang de-
ﬁciency can be presented in the symptoms including declin-
ing libido, soreness, or cold sensation in the knees and lum-
bar regions, spiritual fatigue, and so forth. Both clinical and
animal studies have shown that VAD can promote the de-
velopment of reproduction systems, relieve the pain of arth-
ritis, nourish the neural cells, and so on [1]. These pharma-
cological eﬀects provide empirical evidence for its role of
tonifying kidney Yang.
Heart failure (HF) is a clinical syndrome which all types
of heart diseases will eventually develop into. Evidence from
epidemiological studies has demonstrated that the incidence
of HF in Chinese adults was 0.9%: it reached 0.7% in males
and 1.0% in females [2]. From the perspective of the tradi-
tional chinese medicine (TCM), the primary cause of HF is
heart Yang deﬁciency that results from Qi inadequacy and
blood stasis. According to the heart-kidney-related theory of
TCM, heart Yang originates in kidney Yang, and therefore it
is hypothesized that tonifying kidney Yang could be used to
strengthen heart Yang and treat HF. Indeed, VAD has been
reported to have protective eﬀects on the damaged heart
muscle cells in the animal models of myocardial infarction
via various mechanisms, such as reducing the release of en-
dothelin [3], promoting superoxide dismutase activities, and
decreasing serum malondialdehyde levels [4], and increasing
the levels of nitric oxide and calcitonin-gene-related peptide
[5]. In addition, oral administration of VAD has been found2 Evidence-Based Complementary and Alternative Medicine
tostrengthenthepulse,increasebloodpressure,andenhance
heart sounds for chronic circulatory disorders accompanied
by hypotension [6]. However, to the best of our knowledge,
the therapeutic eﬀects of VAD on the heart failure have not
been fully elucidated due to a lack of clinical and animal
studies.
Leftcoronaryarteryligationisoneofthewidelyusedani-
mal models to mimic myocardial infarction and heart fail-
ure in patients [7]. Echocardiography and serum brain na-
triuretic peptide (BNP) levels are two commonly used in-
dices to evaluate and diagnose heart failure [8]. To provide
empirical evidence for VAD’s clinical application in the treat-
ment of heart diseases, in the current study, we investigated
its therapeutic eﬀects on heart failure following myocardial
infarction with captopril as the positive control by evaluating
echocardiographic parameters and serum BNP levels.
2.Methods and Materials
2.1. Animals and the Heart Failure Model. Male Wistar rats
(N = 48, age 8 weeks, weighing 230 ± 20g) were purchased
from the Institute of Laboratory Animal Science, Chinese
Academy of Medical Sciences, Beijing, China. They were
housed four/cage in a controlled environment (23 ± 1◦C;
45%–50% relative humidity; ﬁxed 12/12h light/dark cycle,
lights on at 08:00h) with food and water ad libitum. All
procedures were performed in accordance with the National
InstituteofHealth’sGuidefortheUseandCareofLaboratory
Animals and were approved by the Committee on Animal
Care and Use of the China-Japan Friendship Hospital.
After seven-day acclimation, animals had their body
weights measured at ﬁrst and then were anesthetized with
intraperitoneal injection of 1% pentobarbital sodium. They
were ﬁxed on their backs, intubated using a 16-gauge ca-
theter, and artiﬁcially ventilated (80 stokes/min, 0.4L/250g)
with a pressure-controlled respirator for small animals
(RSP1002, Kent Scientiﬁc Corporation, CT, USA). An in-
cision of the skin and intercostal muscles was made between
the third and fourth ribs. Under the monitor of a lead 2
electrocardiogram (XJJ-11, Kent Scientiﬁc Corporation, CT,
USA), a thoracotomy was performed and the pericardium
was opened, which left the heart adequately exposed. To in-
duce myocardial infarction, the left coronary artery was lig-
ated 1.5–2mm from the aortic root between the pulmonary
cone and the left auricular appendage with silk sutures.
Then the muscles and skins were sutured and the ventilation
was stopped when rats’ heart rate and respiration went
steady. The sham-operated animals underwent the same
procedure except that the silk suture was placed around the
left coronary artery without being tied. After the surgery, all
animalswereinjectedwithpenicillinforthreedaystoprevent
infection. Six rats with induced myocardial infarction died
during the operation whereas two rats in the sham group
died of infection. The operative mortality was 16.7%.
2.2. Drugs and Pharmacological Procedures. The powder of
velvet antler of deer (VAD, The Scientiﬁc and Technological
Development Center of Qingyuan Manchu Autonomous
County, Liaoning Province, China) and captopril (CAP,
Beijing Shuguang Pharmaceutical Co., Ltd., Beijing, China)
were triturated and then well suspended in double-distilled
water at the doses of 20mg/mL and 1mg/mL respectively.
These doses were calculated according to the conversion
table of animal doses to human equivalent doses based on
body surface area [9]. Provided that the doses of rats should
be seven times lower than those of humans, the clinical dose
of VAD was 2g/70Kg and hence the equivalent dose for rats
is 200mg/Kg. Similarly, the clinical dose of captopril is
100mg/70Kg,andforratsthedoseshouldbe10mg/Kg.One
week after the surgery, animals with myocardial infarction
following left coronary artery ligation received daily treat-
ment of double-distilled water (referred as the HF group),
captopril (the HF + CAP group), or velvet (the HF + VAD
group) by gavage (1mL/100mg body weight) for consecu-
tively four weeks, while sham-operated animals (the SHAM
group) were administered double-distilled water once daily
f o rf o u rw e e k s .
2.3. Measurement of Cardiac Structural and Functional Para-
meters. Echocardiography (HDI 5000, Philips) was per-
formed before rats were sacriﬁced. Under anesthesia by
intraperitoneal injection of 40mg/kg pentobarbital sodium,
rats were ﬁxed on their backs with their fur shaved and
skin cleaned. Using a high-frequency linear-array transducer
(CL15-7),thestructuralparametersoftheheartincludedleft
atrial diameter (LAD), left ventricular end-diastolic diam-
eter (LVDd), left ventricular end-systolic diameter (LVDs),
end-systolic interventricular septal thickness (IVSTs), end-
diastolic interventricular septal thickness (IVSTd), left ven-
tricular end-systolic posterior wall thickness (LVPWTs),
and left ventricular end-diastolic posterior wall thickness
(LVPWTd). Besides, two functional parameters were cal-
culated by the following formulas: left ventricular short-
axis fractional shortening (LVFS) = (LVDd-LVDs)/LVDd,
left ventricular ejection fraction (LVEF) = (LVDd3-L V D s 3)/
LVDd3.
2.4. Brain Natriuretic Peptide (BNP) Measurement. Blood
sampleswerecollectedinEDTAtubes,whichwasthenplaced
on ice and centrifuged within 30min at 4◦C. The plasma was
stored at −80◦C until assay. Radioimmunoassays for rat BNP
were performed as previously reported [10]. Brieﬂy, stan-
dards or samples were incubated with antibody for rat BNP
for 24 hours at 4◦C. 125I-BNP (10000cpm) was then added,
followed by additional incubation for 24 hours at 4◦C. Then
after 90min of incubation with a secondary antibody, free
and bound fractions were separated, and the radioactivity
of the bound fraction was measured by a gamma counter
(EG&G Wallac, USA).
2.5. Statistical Analysis. All data were expressed as means ±
standard deviation. Group diﬀerences were evaluated using
one-way analysis of variance (ANOVA). If the variance of the
data was heterogeneous, the Kruskal-Wallis test was adopted,
which was followed by the Nemenyi multiple comparison
test. P<0.05 was considered to be statistically signiﬁcant.Evidence-Based Complementary and Alternative Medicine 3
Table 1: Comparison of cardiac structural parameters as revealed by echocardiography in rats (¯ x ±s).
Group N LAD (mm) IVSTd (mm) IVSTs (mm) LVPWTd (mm) LVPWTs (mm) LVDd (mm) LVDs (mm)
sham 10 3.31 ±0.15 1.22 ±0.19 1.36 ± 0.20 2.13 ±0.33 2.67 ±0.33 5.79 ±0.74 4.21 ±0.64
HF 9 4.22 ±0.23∗∗∗ 0.68 ±0.14∗∗∗ 0.90 ±0.17∗∗∗ 2.03 ±0.32 2.58 ±0.30 9.79 ±0.66∗∗∗ 8.91 ±0.71∗∗∗
HF + CAP 11 4.42 ±0.22∗∗∗ 0.66 ±0.14∗∗∗ 0.91 ±0.13∗∗∗ 1.88 ±0.23 2.44 ±0.27 10.28 ± 0.69∗∗∗ 9.18 ±0.64∗∗∗
HF + VAD 10 4.31 ±0.30∗∗∗ 0.72 ±0.13∗∗∗ 0.96 ±0.12∗∗∗ 2.87 ±0.33 2.48 ±0.39 .91 ±0.71∗∗∗ 8.59 ±0.63∗∗∗
Notes: ∗∗∗compared to the sham group, P<0.001; HF = heart failure; CAP = captopril; VAD = velvet antler of deer.
Table 2: Comparison of functional parameters as revealed by echocardiography in rats (¯ x ± s).
Group N LVFS (%) LVEF (%)
sham 10 27.20 ±6.16 60.60 ±9.01
HF 9 9.11 ±2.62∗∗∗ 24.67 ±6.44∗∗∗
HF + CAP 11 10.64 ±2.11 32.82 ±5.04Δ
HF + VAD 10 13.40 ±2.91Δ 34.80 ±6.84Δ
Notes: ∗∗∗compared to the sham group, P<0.001; Δ compared to the AMI group, P<0.05. HF = heart failure; CAP = captopril; VAD = velvet antler of deer.
3. Results
3.1.EﬀectsofVADandCAPontheCardiacStructuralParame-
ters in Rats with Heart Failure following Myocardial Infarction
(Table 1). Compared to the SHAM group, the diameters of
left atrium and left ventricle (LAD, LVDd, and LVDs) of
animals in the heart failure groups were signiﬁcantly in-
creased, the interventricular septal thickness (IVSTd and
IVSTs) was decreased (P<0.001) whereas no group diﬀer-
ences were found with respect to LVPWTd and LVPWTs
(P>0.05). VAD and CAP treatment did fail to reverse the
eﬀects of myocardial infarction on cardiac structural param-
eters (P>0.05).
3.2. Eﬀects of VAD andCAPon the CardiacFunctionalParam-
eters in Rats with Heart Failure following Myocardial Infarc-
tion (Table 2). Compared to the SHAM group, animals in
the heart failure groups had signiﬁcantly lower LVFS and
LVEF (P<0.001), indicating that cardiac function was se-
verely impaired by myocardial infarction. Further compar-
isons with the heart failure groups showed that the LVFS of
the VAD group was signiﬁcantly elevated than that of the HF
group(P<0.05) whereas the similar trend in the CAP group
did not reach signiﬁcance (P = 0.377). The LVEFs of both
treatment groups were higher than that of the AMI group
(Ps < 0.05 for the VAD group and the CAP group). These
results indicated that both VAD and CAP partially reversed
the functional damage induced by myocardial infarction. No
diﬀerences were found between the two treatment groups
(P>0.05).
3.3. Eﬀectsof VAD andCAP on SerumBNP Levels in Ratswith
Heart Failure following Myocardial Infarction (Table 3). The
serum BNP levels of the HF group were signiﬁcantly higher
than the sham group (P<0.001), a change that was reversed
by both VAD and CAP treatments (P<0.05). No diﬀerences
were found between the two treatment groups (P>0.05).
Table 3: Serum BNP levels of all groups (¯ x ±s).
Group N BNP (pg/mL)
sham 10 0.89 ±0.21
HF 9 1.31 ±0.21∗∗∗
HF + CAP 11 1.08 ±0.16Δ
HF + VAD 10 1.10 ±0.18Δ
Notes: ∗∗∗ comparedtotheshamgroup,P<0.001;Δcompared to the AMI
group, P<0.05. HF = heart failure; CAP = captopril; VAD = velvet antler of
deer.
4. Discussion
Although there is no such a term as “heart failure” (HF)
in traditional Chinese medicine (TCM), its symptoms can
be classiﬁed into the categories of dyspnea, palpitation, and
edema. This disease is a condition of heart Qi deﬁciency and
heart Yang devitalization due to Zang-Fu dysfunction that
could be resulted from various factors such as improper diet,
overstrain, and repeated invasion of exterior pathogens. The
heart belongs to ﬁre, governs blood and vessels, and controls
spirit. It is a vital organ of the body just like a monarch to
a country and plays a leading role in physical activities. The
kidneybelongstowaterandistheorganwhichstoresessence
as well as true Yin and true Yang. It is the congenital origin
and the root of life. Heart Yang originates in kidney Yang.
Normal physical activities of the human body must rely on
mutual coordination and constraints of these two organs.
The outﬂow of heart Yang is the primary force that warms
kidney Yang. The deﬁciency of Yang in the heart and kidney
leads to weak contraction, which causes vascular obstruction
and blood stasis, and hence the symptoms of heart failure
appear. Just as plain questions: Treatise on disharmony said,
“People who cannot lie down because that will make them
gasp and cough are those who have too much water in their
body.Watergeneratesfromﬂuid.Kidneyisanorganofwater,
governing ﬂuid ﬂows and therefore controls lying down and
gasping as well.” Accordingly, deﬁciency of the heart- and4 Evidence-Based Complementary and Alternative Medicine
kidney Yang is the internal causes of heart failure and plays
the pivotal role in the pathogenesis and prognosis of the
disease.
Previous studies have shown that the TCM syndrome-
typeofratswithheartfailurefollowingmyocardialinfarction
in the current study may belong to the syndrome of deﬁ-
ciency of Qi and blood stasis [11]. The pathogenesis mech-
anisms could be that coronary artery ligation caused blood
stasis in the heart, which leads to Qi damage and produces
symptoms of Qi deﬁciency in the organ and the whole body.
Treatment that promotes blood circulation and replenishes
Qi could improve cardiac function. Considering that Qi def-
iciency could develop into Yang deﬁciency and that kidney
Yang is the origin of heart Yang, it is hypothesized that toni-
fying kidney Yang would strengthen heart Yang, which fur-
thersupplementsheartQiandmakestheheartbeatstronger.
These eﬀects could be beneﬁcial for the treatment of heart
failure.
Based on the heart-kidney-related theory of TCM, in
this study we investigated the therapeutic eﬀects of VAD, a
precious kidney Yang supplementing medicine, on cardiac
structureandfunctionasmeasuredinechocardiographyand
serum BNP levels in rats with HF induced by myocardial
infarction. BNP is a 32-amino-acid polypeptide secreted by
the ventricles of the heart in response to excessive stretching
of heart muscle cells and therefore has been used as an
objective index reﬂecting the immediate condition of cardiac
function and clinical severity of HF [8]. The ﬁnding that
VAD treatment elevated LVFS/LVEF and decreased BNP
levels provides evidence for the protective eﬀects of VAD for
the damaged heart. Recent studies have implicated multiple
mechanisms of VAD in improving cardiac function. For
instance,VADcouldreducethereleaseofendothelin,prevent
vascular contraction in the ischemic regions and enhance
local coronary circulation [3]. VAD has also been reported to
play a protective role on secondary injury of ischemic myo-
cardium by promoting superoxide dismutase activities and
decreasing serum malondialdehyde levels [4]. Lastly, VAD
could elevate the levels of nitric oxide and calcitonin-gene-
related peptide so as to modulate cardiomyocyte apoptosis
[5].
We did not observe the therapeutic eﬀects of VAD in ca-
rdiac structural parameters, a ﬁnding in contrast to a study
showingthatchronictreatmentwithVADcouldsigniﬁcantly
reversetheenlargementofleftventriclecausedbymyocardial
infarction [12]. The inconsistency may be due to that our
study used VAD powder whereas the latter study used the
extractsofVAD,whichcontainsahigherproportionofactive
components. Our ﬁnding that four-week treatment of VAD
showed diﬀerential therapeutic eﬀects on cardiac structure
andfunctionsuggeststhatthetreatmentperiodoffourweeks
may be not long enough to induce structural changes of the
heart as measured by echocardiography. According to our
observation, VAD treatment can also reverse myocardial
ﬁbrosis of HF (unpublished data), which may serve as the
structural basis of functional changes induced by VAD.
In the current study, we used captopril as a positive con-
trol and found that VAD and captopril showed comparable
eﬀects in reversing changes in functional parameters and
BNP levels in rats with heart failure. Although VAD is more
expensive than captopril, it has edges over captopril for pa-
tients with heart failure accompanied with lower blood pres-
sure given the hypotensive side eﬀect of captopril.
In conclusion, the kidney Yang supplementing drug,
VAD,showscomparabletherapeuticeﬀectswithcaptoprilfor
heart failure induced by myocardial infarction as revealed by
functional parameter changes in echocardiography and ser-
um BNP levels. These results provide evidence for the heart-
kidney-related theory of TCM and demonstrate that heart
failure due to heart Yang deﬁciency can be treated by
strengthening kidney Yang. Therefore, VAD might be a po-
tentiallyalternativeandcomplementarymedicineusedinthe
treatment of heart failure.
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